comparemela.com

Latest Breaking News On - Artur saudabayev - Page 1 : comparemela.com

Causaly Raises $60 Million in Series B Funding to Catalyze AI-powered Preclinical Discovery

Causaly Raises $60 Million in Series B Funding to Catalyze AI-powered Preclinical Discovery
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Tel avivNew south walesNew yorkUnited statesWalker sandsAlex gorskyCaroline xieYiannis kiachopoulosVojtech hornaArtur saudabayevOlivier pomelCarlos gonzalez cadenasVisionaries clubNovo nordiskNational institute of environmental health sciencesDrug administration

Causaly, an AI platform for drug discovery and biomedical research, raises $60M

Causaly, an AI platform for drug discovery and biomedical research, raises $60M
techcrunch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from techcrunch.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomCarlos gonzalez cadenasCaroline xieArtur saudabayevYiannis kiachopoulosNational institute of environmental health sciencesDrug administrationNational institutes of healthNovo nordiskVisionaries clubIndex venturesMarathon venture capitalPentech venturesNational instituteEnvironmental health

Causaly Raises $60M in Series B Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

City ofUnited kingdomYiannis kiachopoulosArtur saudabayevOlivier pomelCaroline xieAlex gorskyVisionaries clubLife sciencesDrug administrationNovo nordiskNational institute of environmental health sciencesIndex venturesMarathon venture capitalPentech venturesNational institute

Causaly Raises $60 Million in Series B Funding to Catalyze AI-powered Preclinical Discovery

The financing, led by ICONIQ Growth, enables Causaly to accelerate innovation and drive increased adoption of its category-leading AI platform to modernize scientific research.LONDON & SAN FRANCISCO (BUSINESS WIRE) Causaly, the leading AI platform for biomedical research, closed $60m in Series B funding led by ICO.

New south walesTel avivCity ofUnited kingdomNew yorkUnited statesWalker sandsOlivier pomelArtur saudabayevCaroline xieCarlos gonzalez cadenasYiannis kiachopoulosAlex gorskyDrug administrationNational institute of environmental health sciencesNovo nordisk

Causaly, an AI platform for drug discovery and biomedical research, raises $60M

Artificial intelligence has been a big theme in the world of health and medical research, and specifically in the area of drug discovery. Causaly, a London startup that has built an AI platform to help researchers accelerate the development and testing of drugs, has raised $60 million, a Series B that will be going toward R&D and to continue building out its team. ICONIQ Growth the growth-stage fund affiliated with the iconic investment firm of the same name is leading the round, with previous backers Index Ventures, Marathon Venture Capital, EBRD, Pentech Ventures and Visionaries Club also participating.

City ofUnited kingdomYiannis kiachopoulosCaroline xieArtur saudabayevCarlos gonzalez cadenasNational institute of environmental health sciencesDrug administrationVisionaries clubNovo nordiskNational institutes of healthIndex venturesMarathon venture capitalPentech venturesNational instituteEnvironmental health

vimarsana © 2020. All Rights Reserved.